FDA PMA FDA Class 3 Approved 🇺🇸 United States

Drug-Coated Peripheral Transluminal Angioplasty Catheter

PMA: P190008 · Supplement: S038 · Decision Jan 30, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P190008 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Drug-Coated Peripheral Transluminal Angioplasty Catheter
Trade Name
IN.PACT AV Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
PMA Number
P190008
Supplement Number
S038
Device Class
FDA Class 3
Product Code
PRC
Generic Name
Drug-coated peripheral transluminal angioplasty catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
January 30, 2026
Date Received
April 7, 2025
Supplement Type
135 Review Track For 30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

a visual system with a reticulate as a manufacturing aid during the catheter subassembly welding manufacturing step to aid in ensuring proper overlap between two of the device components

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PRC Drug-Coated Peripheral Transluminal Angioplasty Catheter